AMPK-activation by Metformin in FSGS: AMP-FSGS

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
AMPK-activation by Metformin in FSGS: AMP-FSGS	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, focal segmental glomerulosclerosis, glomerulonephritis, kidney disorder, nephritis, urinary system disorder	Recruiting	Phase 1 / Phase 2	2026-02-03		NCT06090227

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
United States Department of Defense	319
Yale University	458

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Mount Sinai Hospital	New York	United States	225
Yale New Haven Hospital	New Haven	United States	52

Clinical trials